SCHEMBL7540558

SCHEMBL7540558

CC(C)(C)OC(=O)NN(Cc1ccc(-c2ccccc2)cc1)C[C@H](O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 5/20 0.47
CTSK P43235 2/20 0.47
PSEN1 P49768 5/20 0.47
PSEN2 P49810 5/20 0.47
APH1B Q8WW43 5/20 0.47
NCSTN Q92542 5/20 0.47
APH1A Q96BI3 5/20 0.47
PSENEN Q9NZ42 5/20 0.47
MLNR O43193 1/20 0.46
NR1I2 O75469 1/20 0.46
SLCO2B1 O94956 1/20 0.46
ABCB11 O95342 1/20 0.46
ABCB1 P08183 1/20 0.46
UGT1A1 P22309 1/20 0.46
CCKAR P32238 1/20 0.46
OPRK1 P41145 1/20 0.46
GHSR Q92847 1/20 0.46
SLCO1B3 Q9NPD5 1/20 0.46
ABCG2 Q9UNQ0 1/20 0.46
SLCO1B1 Q9Y6L6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710768 0.95 AKT1 (0.49) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL6445086 0.95 AKT1 (0.49) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL6445090 0.95 AKT1 (0.49) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL27535039 0.89 UGT1A1 (0.61) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL6808 0.89 UGT1A1 (0.61) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL6159044 0.89 UGT1A1 (0.61) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL6444022 0.89 PSEN1 (0.59) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL6444025 0.89 PSEN1 (0.59) CTSSCTSKPSEN1PSEN2APH1B
SCHEMBL7480230 0.88 MEN1 (0.43) CTSSPSEN1PSEN2APH1BNCSTN
SCHEMBL7480226 0.88 MEN1 (0.43) CTSSPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876336-B1 AZAHEXANE DERIVATIVES AS SUBSTRATE ISOSTERS OF RETROVIRAL ASPARATE PROTEASES NOVARTIS AG (CH) 2002-06-05 EP disclosed
US-6225345-B1 FOR THERAPY OF ACQUIRED IMMUNODEFICIENCY SYNDROME NOVARTIS AG (CH) 2001-05-01 US disclosed